FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

767972007: Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3682720018 Product containing dehydrocholic acid and pancreatin and simeticone in oral dosage form (medicinal product form) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3682721019 Dehydrocholic acid and pancreatin and simethicone in oral dosage form en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3682722014 Dehydrocholic acid and pancreatin and simeticone in oral dosage form en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3682724010 Product containing dehydrocholic acid and pancreatin and simeticone in oral dosage form en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3709464010 Dehydrocholic acid- and pancreatin- and simethicone-containing product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3709465011 Dehydrocholic acid- and pancreatin- and simeticone-containing product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3709466012 Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) Is a Product containing dehydrocholic acid and pancreatin and simeticone false Inferred relationship Some
    Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Simeticone false Inferred relationship Some 3
    Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) Has manufactured dose form Oral dose form false Inferred relationship Some
    Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) Is a Simeticone-containing product in oral dose form false Inferred relationship Some
    Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. A substance containing enzymes, mainly amylase, lipase, and protease, obtained from the pancreas of the hog or of the ox. It is a cream-coloured, amorphous powder, having a faint, characteristic, but not offensive odour. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancreatin contains, in each mg, not less than 25 USP units of amylase activity, not less than 2 USP units of lipase activity, and not less than 25 USP units of protease activity. Pancreatin of a higher digestive power may be labelled as a whole-number multiple of the 3 minimum activities, or may be diluted with lactose, or with sucrose containing not more than 3.25% of starch, or with pancreatin of lower digestive power. false Inferred relationship Some 1
    Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dehydrocholic acid (substance) false Inferred relationship Some 2
    Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) Is a Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) false Inferred relationship Some
    Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) Plays role Digestant therapeutic role (role) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    dehydrocholsyre 180 mg + dimethicon 40 mg + pancreatin 300 mg tablet Is a False Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) Inferred relationship Some
    Product containing only dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) Is a False Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start